替格瑞洛——抗血小板治疗领域是否需要新的参与者？ - Suppr

Suppr

超能文献

Ticagrelor--is there need for a new player in the antiplatelet-therapy field?

作者信息

Schömig Albert

出版信息

N Engl J Med. 2009 Sep 10;361(11):1108-11. doi: 10.1056/NEJMe0906549. Epub 2009 Aug 30.

DOI:10.1056/NEJMe0906549

PMID:19717845

Abstract

摘要

相似文献

Ticagrelor--is there need for a new player in the antiplatelet-therapy field?替格瑞洛——抗血小板治疗领域是否需要新的参与者？

N Engl J Med. 2009 Sep 10;361(11):1108-11. doi: 10.1056/NEJMe0906549. Epub 2009 Aug 30.

Ticagrelor in ACS: redefining a new standard of care?替格瑞洛用于急性冠状动脉综合征：重新定义护理新标准？

Lancet. 2010 Jan 23;375(9711):263-5. doi: 10.1016/S0140-6736(10)60070-0. Epub 2010 Jan 13.

Role of ticagrelor in clopidogrel nonresponders: resistance is futile?替格瑞洛在氯吡格雷无反应者中的作用：抵抗是否徒劳？

Circulation. 2010 Mar 16;121(10):1169-71. doi: 10.1161/CIR.0b013e3181d8d929. Epub 2010 Mar 1.

Ticagrelor versus clopidogrel in acute coronary syndromes.

N Engl J Med. 2009 Dec 10;361(24):2386-7; author reply 2387-8.

Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?替格瑞洛--急性冠脉综合征患者的新型血小板聚集抑制剂。能改善其他抑制剂吗？

Med Sci Monit. 2009 Dec;15(12):MS24-30.

Development and clinical use of prasugrel and ticagrelor.普拉格雷和替格瑞洛的研发与临床应用。

Curr Pharm Des. 2012;18(33):5240-60. doi: 10.2174/138161212803251989.

Prasugrel vs. ticagrelor in acute coronary syndromes: which one to choose?普拉格雷与替格瑞洛在急性冠状动脉综合征中的应用：如何选择？

Wien Klin Wochenschr. 2011 Aug;123(15-16):468-76. doi: 10.1007/s00508-011-0027-7. Epub 2011 Aug 3.

Ticagrelor versus clopidogrel in acute coronary syndromes.

N Engl J Med. 2009 Dec 10;361(24):2386; author reply 2387-8.

Ticagrelor versus clopidogrel in acute coronary syndromes.

N Engl J Med. 2009 Dec 10;361(24):2385; author reply 2387-8. doi: 10.1056/NEJMc0909586.

Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome.基因型指导与双联抗血小板治疗急性冠脉综合征的成本效果分析。

Ann Intern Med. 2014 Feb 18;160(4):221-32. doi: 10.7326/M13-1999.

引用本文的文献

Ticagrelor versus clopidogrel in loss-of-function carriers with stroke or TIA stratified by age and renal function: CHANCE-2 trial substudy.替格瑞洛与氯吡格雷在按年龄和肾功能分层的卒中或短暂性脑缺血发作功能丧失携带者中的比较：CHANCE-2试验子研究

Ren Fail. 2025 Dec;47(1):2526684. doi: 10.1080/0886022X.2025.2526684. Epub 2025 Jul 23.

Current and Novel Emerging Medical Therapies for Peripheral Artery Disease: A Literature Review.外周动脉疾病的当前和新型新兴医学疗法：文献综述

Adv Pharm Bull. 2023 Mar;13(2):259-268. doi: 10.34172/apb.2023.025. Epub 2022 Apr 4.

Antithrombotic Therapy after Deep Venous Intervention.深静脉介入后的抗栓治疗。

Semin Intervent Radiol. 2022 Nov 17;39(4):357-363. doi: 10.1055/s-0042-1757340. eCollection 2022 Aug.

Comparative Effectiveness of Ticagrelor, Prasugrel, and Clopidogrel for Secondary Prophylaxis in Acute Coronary Syndrome: A Propensity Score-Matched Cohort Study.替格瑞洛、普拉格雷和氯吡格雷用于急性冠状动脉综合征二级预防的疗效比较：一项倾向评分匹配队列研究。

Clin Pharmacol Ther. 2023 Feb;113(2):401-411. doi: 10.1002/cpt.2797. Epub 2022 Dec 13.

Challenges in Patient Blood Management for Cardiac Surgery: A Narrative Review.心脏手术患者血液管理面临的挑战：一项叙述性综述

J Clin Med. 2021 Jun 1;10(11):2454. doi: 10.3390/jcm10112454.

Management of asymptomatic carotid stenosis.无症状性颈动脉狭窄的管理

Ann Transl Med. 2020 Oct;8(19):1262. doi: 10.21037/atm-20-975.

2020 Focused Update of the 2012 Guidelines of the Taiwan Society of Cardiology for the Management of ST-Segment Elevation Myocardial Infarction.《2012年台湾心脏病学会ST段抬高型心肌梗死管理指南2020年聚焦更新》

Acta Cardiol Sin. 2020 Jul;36(4):285-307. doi: 10.6515/ACS.202007_36(4).20200619A.

Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST-Segment-Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long-Term Follow-Up of the REDUCE-MVI Trial.血小板抑制、内皮功能和 ST 段抬高型心肌梗死患者接受替格瑞洛与普拉格雷维持治疗的临床结局：REDCUE-MVI 试验的长期随访。

J Am Heart Assoc. 2020 Mar 3;9(5):e014411. doi: 10.1161/JAHA.119.014411.

Ticagrelor and clopidogrel suppress NF-κB signaling pathway to alleviate LPS-induced dysfunction in vein endothelial cells.替格瑞洛和氯吡格雷抑制 NF-κB 信号通路减轻 LPS 诱导的静脉内皮细胞功能障碍。

BMC Cardiovasc Disord. 2019 Dec 30;19(1):318. doi: 10.1186/s12872-019-01287-1.

Pharmacogenomic considerations for antiplatelet agents: the era of precision medicine in stroke prevention and neurointerventional practice.抗血小板药物的药物基因组学考量：卒中预防与神经介入实践中的精准医学时代

Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). doi: 10.1101/mcs.a003731. Print 2019 Apr.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验